Cenicriviroc + Tropifexor

Cenicriviroc and Tropifexor combination therapy are compounds being investigated for non-alcoholic steatohepatitis.

Type of Molecule

Small Molecule

Target

CCR2 CCR5 Inhibitor , FXR Agonist

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted)
Non-alcoholic Steatohepatitis (NASH) n/a
Phase 2